Vitamin-One Formulas Ltd (dba VitaminLab), a Victoria, BC, Canada-based leader in personalized supplements designed to meet individual health needs, closed a Series A investment round of undisclosed amount.
The round was co-led by Nimbus Synergies and DSM Venturing.
The company intends to use the proceeds of the financing to expand its facilities and automation lines as well as scale its go-to-market activities across North America.
Led by Anton Solonnikov, CEO, VitaminLab leverages an evidence-based, approach that considers multiple data points of an individual including health history, blood test results, and DNA. The personalized supplement is created using a proprietary process and machinery and formulated from a comprehensive nutrient list of more than 200 high-quality ingredients. VitaminLab has been growing rapidly through direct-to-consumer e-commerce, integrated healthcare practitioners and integrations with leading health testing companies.
As part of the investment, Greg McParland, Investment Director of DSM Venturing, will join the Board along with Laura Cassin, Investment Associate of Nimbus Synergies, who has been on the Board since November 2022.
FinSMEs
08/05/2023